格列卫(Gleevec)这种广为宣传的抗白血病药物在这里成了现代基因癌症治疗的英雄,是一种“理性设计”出来专门针对特定肿瘤基因的药物。
The much touted anti-leukemia drug Gleevec here appears as the hero of modern, genetics-based cancer therapy, a “rationally designed” drug specifically directed against a known cancer gene.
最新研究表明新的靶向治疗药物SU11248对格列卫耐药的患者有延长生存期的作用。
Recent research shows that a new targeting therapeutic agent, SU11248, can prolong the survival time of the patients with GISTs who were resistant to Gleevec therapy.
应用推荐